{"protocolSection":{"identificationModule":{"nctId":"NCT01073007","orgStudyIdInfo":{"id":"STARS07"},"secondaryIdInfos":[{"id":"EC07/90195","type":"OTHER","domain":"Fondo de Investigación Sanitaria"}],"organization":{"fullName":"Hospital Universitari Vall d'Hebron Research Institute","class":"OTHER"},"briefTitle":"Stroke Treatment With Acute Reperfusion and Simvastatin","officialTitle":"Multicentric, Randomized, Double-blind Clinical Trial to Evaluate the Efficacy of Simvastatin in the Acute Phase of Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2014-06","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2009-04"},"primaryCompletionDateStruct":{"date":"2014-06","type":"ACTUAL"},"completionDateStruct":{"date":"2014-06","type":"ACTUAL"},"studyFirstSubmitDate":"2010-02-18","studyFirstSubmitQcDate":"2010-02-19","studyFirstPostDateStruct":{"date":"2010-02-22","type":"ESTIMATED"},"lastUpdateSubmitDate":"2016-12-20","lastUpdatePostDateStruct":{"date":"2016-12-21","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Hospital Universitari Vall d'Hebron Research Institute","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The purpose of this study is to determine whether simvastatin treatment started within the first 12 hours from stroke onset improves neurological and functional outcomes, evaluated at seventh day/discharge or at the third month.\n\nAlso, to demonstrate that simvastatin is safe and not associated with higher rates of hemorrhagic transformation in patients who receive thrombolysis."},"conditionsModule":{"conditions":["Stroke, Acute"],"keywords":["Acute Stroke","tissue plasminogen activator","simvastatin"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE4"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":104,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Simvastatin","type":"EXPERIMENTAL","description":"Simvastatin 40 mg daily for 3 months.","interventionNames":["Drug: Simvastatin"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Simvastatin"]}],"interventions":[{"type":"DRUG","name":"Simvastatin","description":"Simvastatin 40 mgrs daily for three months.","armGroupLabels":["Placebo","Simvastatin"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"The primary outcome of this study is to determine whether simvastatin treatment started within the first 12 hours from stroke onset improves neurological and functional outcomes, evaluated at seventh day/discharge or at the third month.","timeFrame":"Seventh day (or discharge) and third month"}],"secondaryOutcomes":[{"measure":"The secondary outcome of this study is to demonstrate that simvastatin is safe and not associated with higher rates of hemorrhagic transformation in patients who receive thrombolysis.","timeFrame":"24 to 78 hours"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients older than 18 years acute ischemic stroke (less than 12 hours from stroke onset).\n* Stroke involving MCA-ACA-PCA.\n* NIHSS score 4 to 22.\n* Previous modified Rankin Scale score of 1 or 0.\n* Patient or proxy informed consent.\n* Patients not taking statins for the past six months.\n\nExclusion Criteria:\n\n* Pregnancy or breastfeeding.\n* Clinical or radiological evidence on admission of intracranial hemorrhage, hemorrhagic infarction or tumor.\n* Seizures at the time of inclusion.\n* Complete or substantial recovery prior to randomization.\n* Patients with ipsilateral neurological deficit that may mask the evaluation of the current event.\n* Liver disease (AST or ALT more than twice upper normality limit).\n* Cardiogenic shock or relevant cardiac failure.\n* Patients with more than five times upper normality limit of CPK.\n* Myocardial infarction or any other thromboembolic event within the previous 30 days.\n* Active infection by the time of inclusion.\n* Documented hypersensibility to statins.\n* Drug abuse.\n* Expected short life-expectancy related to other systemic diseases.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Joan Montaner, MD, PhD","affiliation":"Hospital Vall Hebron Research Institute","role":"STUDY_DIRECTOR"},{"name":"Marc Ribó, MD, PhD","affiliation":"Hospital Vall Hebron. Stroke Unit","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Carmen Jimenez, MD","affiliation":"Hospital Son Dureta. Stroke Unit.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Francesc Muñoz, MD","affiliation":"Hospital de Mollet","role":"PRINCIPAL_INVESTIGATOR"},{"name":"David Canovas, MD","affiliation":"Consorci Sanitari Parc Taulí Sabadell.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Jurek Krupinski, MD","affiliation":"Hospital Mutua de Terrassa. Neurology Department","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Maite Martinez-Zabaleta, MD","affiliation":"Hospital de Donostia. Neurology Department","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Francisco Javier De la Torre Laviana, MD","affiliation":"Hospital Virgen del Rocio. Stroke Unit.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Marimar Freijo, MD","affiliation":"Hospital de Basurto","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Tomás Segura, MD","affiliation":"Hospital Universitario de Albacete","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Juan Arenillas, MD, PhD","affiliation":"Hospital Universitario de Valladolid","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Jose Manuel Flores, MD","affiliation":"Hospital de Ciudad Real","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Francisco Alonso, MD, PhD","affiliation":"Hospital General de Vic","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Jaime Masjuán Vallejo, MD","affiliation":"Hospital Universitario Ramón y Cajal. Stroke unit.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Francisco Rubio Borrego, MD, PhD","affiliation":"Hospital Universitario de Bellvitge. Stroke Unit.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Javier Tejada García, MD","affiliation":"Hospital de Leon","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Aida Lago Martín, MD, PhD","affiliation":"Hospital Universitario la Fe. Stroke Unit.","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Yolanda Bravo Anguiano, MD","affiliation":"Hospital General Yagüe","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Xavier Ustrell Roig, MD, PhD","affiliation":"Hospital Universitario Joan XXIII","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Francisco Purroy García, MD, PhD","affiliation":"Hospital Universitario Arnau de Vilanova de Lleida","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Raquel Delgado Mederos, MD, PhD","affiliation":"Hospital Santa Creu i Sant Pau","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Hospital General de Vic","city":"Vic","state":"Barcelona","country":"Spain","geoPoint":{"lat":41.93012,"lon":2.25486}},{"facility":"Hospital Universitario de Albacete","city":"Albacete","country":"Spain","geoPoint":{"lat":38.99424,"lon":-1.85643}},{"facility":"Hospital de Santa Creu i Sant Pau","city":"Barcelona","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital Universitario de Bellvitge","city":"Barcelona","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital Universitario Vall d'Hebron","city":"Barcelona","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital de Basurto","city":"Bilbao","country":"Spain","geoPoint":{"lat":43.26271,"lon":-2.92528}},{"facility":"Hospital General Yagüe","city":"Burgos","country":"Spain","geoPoint":{"lat":42.34106,"lon":-3.70184}},{"facility":"Hospital de Ciudad Real","city":"Ciudad Real","country":"Spain","geoPoint":{"lat":38.98626,"lon":-3.92907}},{"facility":"Hospital de Donostia","city":"Donostia","country":"Spain","geoPoint":{"lat":43.31283,"lon":-1.97499}},{"facility":"Hospital de León","city":"León","country":"Spain","geoPoint":{"lat":42.60003,"lon":-5.57032}},{"facility":"Hospital Arnau de Vilanova de Lleida","city":"Lleida","country":"Spain","geoPoint":{"lat":41.61674,"lon":0.62218}},{"facility":"Hospital Universitario Ramón y Cajal","city":"Madrid","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"Hospital de Mollet","city":"Mollet del Vallès","country":"Spain","geoPoint":{"lat":41.54026,"lon":2.21306}},{"facility":"Hospital Son Dureta","city":"Palma de Mallorca","country":"Spain","geoPoint":{"lat":39.56939,"lon":2.65024}},{"facility":"Consorci Sanitari Parc Tauli","city":"Sabadell","country":"Spain","geoPoint":{"lat":41.54329,"lon":2.10942}},{"facility":"Hospital Virgen del Rocío","city":"Sevilla","country":"Spain","geoPoint":{"lat":37.38283,"lon":-5.97317}},{"facility":"Hospital Universitario Joan XXIII","city":"Tarragona","country":"Spain","geoPoint":{"lat":41.11667,"lon":1.25}},{"facility":"Hospital Mutua de Terrassa","city":"Terrassa","country":"Spain","geoPoint":{"lat":41.56667,"lon":2.01667}},{"facility":"Hospital Universitario La Fe","city":"Valencia","country":"Spain","geoPoint":{"lat":39.46975,"lon":-0.37739}},{"facility":"Hospital Universitario de Valladolid","city":"Valladolid","country":"Spain","geoPoint":{"lat":41.65518,"lon":-4.72372}}]},"referencesModule":{"references":[{"pmid":"27758944","type":"DERIVED","citation":"Montaner J, Bustamante A, Garcia-Matas S, Martinez-Zabaleta M, Jimenez C, de la Torre J, Rubio FR, Segura T, Masjuan J, Canovas D, Freijo M, Delgado-Mederos R, Tejada J, Lago A, Bravo Y, Corbeto N, Giralt D, Vives-Pastor B, de Arce A, Moniche F, Delgado P, Ribo M; STARS Investigators. Combination of Thrombolysis and Statins in Acute Stroke Is Safe: Results of the STARS Randomized Trial (Stroke Treatment With Acute Reperfusion and Simvastatin). Stroke. 2016 Nov;47(11):2870-2873. doi: 10.1161/STROKEAHA.116.014600. Epub 2016 Oct 6."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000019821","term":"Simvastatin"}],"ancestors":[{"id":"D000000924","term":"Anticholesteremic Agents"},{"id":"D000000960","term":"Hypolipidemic Agents"},{"id":"D000000963","term":"Antimetabolites"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000057847","term":"Lipid Regulating Agents"},{"id":"D000019161","term":"Hydroxymethylglutaryl-CoA Reductase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"}],"browseLeaves":[{"id":"M13539","name":"Tissue Plasminogen Activator","relevance":"LOW"},{"id":"M21403","name":"Simvastatin","asFound":"Elderly","relevance":"HIGH"},{"id":"M13538","name":"Plasminogen","relevance":"LOW"},{"id":"M3933","name":"Anticholesteremic Agents","relevance":"LOW"},{"id":"M3968","name":"Hypolipidemic Agents","relevance":"LOW"},{"id":"M3971","name":"Antimetabolites","relevance":"LOW"},{"id":"M28573","name":"Lipid Regulating Agents","relevance":"LOW"},{"id":"M20845","name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"}],"browseBranches":[{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Lipd","name":"Lipid Regulating Agents"}]}},"hasResults":false}